- Report
- August 2025
- 264 Pages
Global
From €4620EUR$4,995USD£3,856GBP
- Report
- June 2024
- 270 Pages
Global
From €4620EUR$4,995USD£3,856GBP
- Report
- March 2026
- 381 Pages
China
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 170 Pages
Germany
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 342 Pages
Canada
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 209 Pages
India
From €4486EUR$4,850USD£3,744GBP
- Report
- October 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- July 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- April 2023
- 180 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- December 2022
- 122 Pages
North America
From €3191EUR$3,450USD£2,663GBP
- Report
- August 2022
- 273 Pages
Europe
From €3191EUR$3,450USD£2,663GBP
- Report
- January 2023
- 220 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- May 2022
- 347 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- April 2024
- 100 Pages
Africa
From €1850EUR$2,000USD£1,544GBP
- Report
- April 2024
- 80 Pages
China
From €1387EUR$1,500USD£1,158GBP
- Report
- April 2024
- 80 Pages
France
From €1387EUR$1,500USD£1,158GBP
- Report
- April 2024
- 80 Pages
Germany
From €1387EUR$1,500USD£1,158GBP
- Report
- April 2024
- 80 Pages
India
From €1387EUR$1,500USD£1,158GBP
- Report
- April 2024
- 80 Pages
Russia
From €1387EUR$1,500USD£1,158GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1387EUR$1,500USD£1,158GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more